Market Tracker

02/21 5:16pm ET

Novogen Ltd (NASDAQ:NVGN)

1.61
Delayed Data
As of 3:59pm ET
 -0.13 / -7.47%
Today’s Change
1.39
Today|||52-Week Range
2.85
+9.90%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.74
Today’s open1.77
Day’s range1.58 - 1.77
Volume28,468
Average volume (3 months)27,418
Market cap$29.9M
Dividend yield--
Data as of 3:59pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-66.37%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...-0.00-2.77%
OGENOragenics Inc+0.01+1.59%
RPRXRepros Therapeutics ...-0.01-1.23%
MRNSMarinus Pharmaceutic...-0.01-0.68%
Data as of 3:59pm ET, 02/21/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts